EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso‐occlusive pain: A multicenter pediatric emergency medicine perspective

Chris A Rees iD, David C Brousseau, Fahd A Ahmad iD, Jonathan Bennett, Seema Bhatt, Amanda Bogie, Kathleen M Brown, T Charles Casper, Laura L Chapman, Corrie E Chumpitazi, Daniel M Cohen, Carlton Dampier und 14 weitere

American Journal of Hematology · 2023

DOI: 10.1002/ajh.26837 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Hematology, 2023. Verfasst von Chris A Rees und 25 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Emergency Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Pediatric Emergency Medicine, Anemia, Sickle Cell. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Children with sickle cell disease (SCD) commonly experience vaso‐occlusive pain episodes (VOE) due to sickling of erythrocytes, which often requires care in the emergency department. Our objective was to assess the use and impact of intranasal fentanyl for the treatment of children with SCD‐VOE on discharge from the emergency department in a multicenter study. We conducted a cross‐sectional study at 20 academic pediatric emergency departments in the United States and Canada. We used logistic regression to test bivariable and multivariable associations between the outcome of discharge from the emergency department and candidate variables theoretically associated with discharge. The study included 400 patients; 215 (54%) were female. The median age was 14.6 (interquartile range 9.8, 17.6) years. Nineteen percent ( n = 75) received intranasal fentanyl in the emergency department. Children who received intranasal fentanyl had nearly nine‐fold greater adjusted odds of discharge from the emergency department compared to those who did not (adjusted odds ratio 8.99, 95% CI 2.81–30.56, p < .001). The rapid onset of action and ease of delivery without intravenous access offered by intranasal fentanyl make it a feasible initial parenteral analgesic in the treatment of children with SCD presenting with VOE in the acute‐care setting. Further study is needed to determine potential causality of the association between intranasal fentanyl and discharge from the emergency department observed in this multicenter study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pediatric Emergency MedicineAnemia, Sickle CellHumansChildFemaleMaleFentanylPatient DischargeCross-Sectional StudiesPainEmergency Service, HospitalAnalgesics, Opioid

Substanzen

FentanylAnalgesics, Opioid

Autor:innen und Institutionen

  • Division of Pediatric Emergency Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Section of Pediatric Emergency Medicine, Medical College of Wisconsin and the Children's Research Institute of the Children's Hospital of Wisconsin, Milwaukee, Wisconsin, USA.
  • Division of Emergency Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Alfred I. DuPont Hospital for Children, Wilmington, Delaware, USA.
  • Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID-Profile: Chris A Rees, Fahd A Ahmad, Lewis L Hsu, Claudia R Morris

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • NCATS NIH HHS
  • NCCIH NIH HHS
  • Doris Duke Charitable Foundation
  • National Center for Complementary and Integrative Health
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health

Zitieren

APA

Rees, C. A., Brousseau, D. C., Ahmad, F. A., Bennett, J., Bhatt, S., Bogie, A., Brown, K. M., Casper, T. C., Chapman, L. L., Chumpitazi, C. E., Cohen, D. M., Dampier, C., Ellison, A. M., Grasemann, H., Hatabah, D., Hickey, R. W., Hsu, L. L., Bakshi, N., Leibovich, S., …, & SCD Arginine Study Group and PECARN (2023). Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso‐occlusive pain: A multicenter pediatric emergency medicine perspective. American Journal of Hematology. https://doi.org/10.1002/ajh.26837

Vancouver

Rees CA, Brousseau DC, Ahmad FA, Bennett J, Bhatt S, Bogie A, et al. Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso‐occlusive pain: A multicenter pediatric emergency medicine perspective. American Journal of Hematology. 2023. doi:10.1002/ajh.26837

BibTeX
@article{Rees2023,
  author = {Rees, Chris A and Brousseau, David C and Ahmad, Fahd A and Bennett, Jonathan and Bhatt, Seema and Bogie, Amanda and Brown, Kathleen M and Casper, T Charles and Chapman, Laura L and Chumpitazi, Corrie E and Cohen, Daniel M and Dampier, Carlton and Ellison, Angela M and Grasemann, Hartmut and Hatabah, Dunia and Hickey, Robert W and Hsu, Lewis L and Bakshi, Nitya and Leibovich, Sara and Patil, Prabhumallikarjun and Powell, Elizabeth C and Richards, Rachel and Sarnaik, Syana and Weiner, Debra L and Morris, Claudia R and SCD Arginine Study Group and PECARN, SCD Arginine Study Group and PECARN},
  title = {Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso‐occlusive pain: A multicenter pediatric emergency medicine perspective},
  journal = {American Journal of Hematology},
  year = {2023},
  doi = {10.1002/ajh.26837}
}
Kostenlos starten →